The bispecific boom: Genentech pays $120M to tie the knot with Xencor on an IL-15 alliance

The bispecific boom: Genentech pays $120M to tie the knot with Xencor on an IL-15 alliance

Submitted by admin on February 5, 2019 - 10:05am
Source: 
Endpoints
News Tags: 
Genentech
Xencor
IL-15
XmAb24306
cancer
bispecific antibodies
Headline: 
The bispecific boom: Genentech pays $120M to tie the knot with Xencor on an IL-15 alliance
snippet: 

Genentech is fronting $120 million to partner up with Xencor $XNCR on its IL-15 cytokine work, nabbing co-development rights to the late preclinical drug XmAb24306 along with future candidates to come.

Do Not Allow Advertisers to Use My Personal information